Cargando…

SPON1 Is Associated with Amyloid-β and APOE ε4-Related Cognitive Decline in Cognitively Normal Adults

Abstract. BACKGROUND: Genetic variation in Spondin-1, specifically rs11023139, has been associated with reduced rates of cognitive decline in individuals with Alzheimer’s disease. OBJECTIVE: The aim of this study was to assess whether the association was present in cognitively normal older adults. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernandez, Shane, Burnham, Samantha C., Milicic, Lidija, Savage, Greg, Maruff, Paul, Peretti, Madeline, Sohrabi, Hamid R., Lim, Yen Ying, Weinborn, Michael, Ames, David, Masters, Colin L., Martins, Ralph N., Rainey-Smith, Stephanie, Rowe, Christopher C., Salvado, Olivier, Groth, David, Verdile, Giuseppe, Villemagne, Victor L., Porter, Tenielle, Laws, Simon M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2021
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990462/ https://www.ncbi.nlm.nih.gov/pubmed/33782664 http://dx.doi.org/10.3233/ADR-200246

Ejemplares similares

COMT val158met is not associated with Aβ-amyloid and APOE ε4 related cognitive decline in cognitively normal older adults
por: Porter, Tenielle, et al.
Publicado: (2019)

KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4-positive cognitively normal adults with high Aβ-amyloid burden
por: Porter, Tenielle, et al.
Publicado: (2018)

A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer’s Disease
por: Porter, Tenielle, et al.
Publicado: (2018)

Genetic variation in Aquaporin-4 moderates the relationship between sleep and brain Aβ-amyloid burden
por: Rainey-Smith, Stephanie R., et al.
Publicado: (2018)

Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults
por: Laws, Simon M., et al.
Publicado: (2017)

Validation of a priori candidate Alzheimer’s disease SNPs with brain amyloid-beta deposition
por: Vacher, Michael, et al.
Publicado: (2019)

Learning deficit in cognitively normal APOE ε4 carriers with LOW β‐amyloid
por: Lim, Yen Ying, et al.
Publicado: (2021)

Amyloid-Related Memory Decline in Preclinical Alzheimer’s Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months
por: Thai, Christine, et al.
Publicado: (2015)

Longitudinal Trajectories in Cortical Thickness and Volume Atrophy: Superior Cognitive Performance Does Not Protect Against Brain Atrophy in Older Adults
por: Gardener, Samantha L., et al.
Publicado: (2021)

Using imputation to provide harmonized longitudinal measures of cognition across AIBL and ADNI
por: Shishegar, Rosita, et al.
Publicado: (2021)

Amyloid β–associated cognitive decline in the absence of clinical disease progression and systemic illness
por: Harrington, Karra D., et al.
Publicado: (2017)

Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume
por: Milicic, Lidija, et al.
Publicado: (2022)

APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease
por: Lim, Y Y, et al.
Publicado: (2015)

Mediterranean diet adherence and rate of cerebral Aβ-amyloid accumulation: Data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing
por: Rainey-Smith, Stephanie R., et al.
Publicado: (2018)

Rates of age- and amyloid β-associated cortical atrophy in older adults with superior memory performance
por: Dang, Christa, et al.
Publicado: (2019)

Association of β-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older Individuals
por: van der Kall, Laura M., et al.
Publicado: (2021)

Assessment of a polygenic hazard score for the onset of pre-clinical Alzheimer’s disease
por: Vacher, Michael, et al.
Publicado: (2022)

Utility of DNA Methylation as a Biomarker in Aging and Alzheimer’s Disease
por: Milicic, Lidija, et al.
Publicado: (2023)

Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer’s Disease Patients and Correlates with Cognitive Performance
por: Pedrini, Steve, et al.
Publicado: (2020)

Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer’s Disease
por: Fowler, Christopher, et al.
Publicado: (2021)

High-intensity exercise and cognitive function in cognitively normal older adults: a pilot randomised clinical trial
por: Brown, Belinda M., et al.
Publicado: (2021)

Study protocol of the Intense Physical Activity and Cognition study: The effect of high-intensity exercise training on cognitive function in older adults
por: Brown, Belinda M., et al.
Publicado: (2017)

The Effects of Latrepirdine on Amyloid-β Aggregation and Toxicity
por: Porter, Tenielle, et al.
Publicado: (2016)

A combination of physical activity and computerized brain training improves verbal memory and increases cerebral glucose metabolism in the elderly
por: Shah, T, et al.
Publicado: (2014)

Intense physical activity is associated with cognitive performance in the elderly
por: Brown, B M, et al.
Publicado: (2012)

Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study
por: Gardener, Samantha L., et al.
Publicado: (2021)

SPON1 Can Reduce Amyloid Beta and Reverse Cognitive Impairment and Memory Dysfunction in Alzheimer’s Disease Mouse Model
por: Park, Soo Yong, et al.
Publicado: (2020)

SPON1 is an independent prognostic biomarker for ovarian cancer
por: Miyakawa, Ryoya, et al.
Publicado: (2023)

The role of APOE-ɛ4 and beta amyloid in the differential rate of recovery from ECT: a review
por: Sutton, T A, et al.
Publicado: (2015)

Current Insights on the Use of Insulin and the Potential Use of Insulin Mimetics in Targeting Insulin Signalling in Alzheimer’s Disease
por: Woodfield, Amy, et al.
Publicado: (2022)

Is APOE ε4 associated with cognitive performance in early MS?
por: Engel, Sinah, et al.
Publicado: (2020)

Hair and salivary cortisol and their relationship with lifestyle, mood and cognitive outcomes in premanifest Huntington’s disease
por: Cruickshank, Travis, et al.
Publicado: (2021)

Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease
por: Frost, S, et al.
Publicado: (2013)

Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer’s disease
por: Maruff, Paul, et al.
Publicado: (2013)

APOE-ε4 modulates the association between regional amyloid deposition and cognitive performance in cognitively unimpaired middle-aged individuals
por: Brugulat-Serrat, Anna, et al.
Publicado: (2023)

SponDT (Spondylodiscitis Diagnosis and Treatment): spondylodiscitis scoring system
por: Homagk, Lars, et al.
Publicado: (2019)

Subjective cognitive decline, APOE ε4, and incident mild cognitive impairment in men and women
por: Müller-Gerards, Diana, et al.
Publicado: (2019)

The Association Between Alzheimer's Disease-Related Markers and Physical Activity in Cognitively Normal Older Adults
por: Pedrini, Steve, et al.
Publicado: (2022)

Intake of Products Containing Anthocyanins, Flavanols, and Flavanones, and Cognitive Function: A Narrative Review
por: Gardener, Samantha L., et al.
Publicado: (2021)

Sleep, Sirtuin 1 and Alzheimer’s disease: A review
por: Mehramiz, Mehrane, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jcg1eqs1padqk6dijvl4j7ik2m